# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Northland Capital Markets analyst Tim Savageaux maintains MaxLinear (NASDAQ:MXL) with a Outperform and lowers the price targ...
Craig-Hallum analyst Richard Shannon maintains MaxLinear (NASDAQ:MXL) with a Hold and lowers the price target from $38 to $28.
EW: -24% | Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and is...